Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir-containing regimen: Results from a retreatment study.
Saved in:
| Title: | Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir-containing regimen: Results from a retreatment study. |
|---|---|
| Authors: | Ruane P; Ruane Medical and Liver Health Institute, Los Angeles, California., Strasser SI; AW Morrow Gastroenterology and Liver Centre, Sydney, NSW, Australia., Gane EJ; University of Auckland, Auckland, New Zealand., Hyland RH; Gilead Sciences Inc., Foster City, California., Shao J; Gilead Sciences Inc., Foster City, California., Dvory-Sobol H; Gilead Sciences Inc., Foster City, California., Tran T; Gilead Sciences Inc., Foster City, California., Stamm LM; Gilead Sciences Inc., Foster City, California., Brainard DM; Gilead Sciences Inc., Foster City, California., Nyberg L; Kaiser Permanente, San Diego, California., Shafran S; University of Alberta, Edmonton, AB, Canada. |
| Source: | Journal of viral hepatitis [J Viral Hepat] 2019 Jun; Vol. 26 (6), pp. 770-773. Date of Electronic Publication: 2019 Feb 27. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 9435672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2893 (Electronic) Linking ISSN: 13520504 NLM ISO Abbreviation: J Viral Hepat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1365-2893 |
|---|---|
| DOI: | 10.1111/jvh.13067 |
